News | February 22, 2010

Complimentary Atrial Fibrillation Symposium is March 13 at ACC

February 22, 2010 – The session “The Future is Now: Changing Paradigms in Atrial Fibrillation (AF) Management,” will take place 8 a.m. to noon Saturday, March 13 in Atlanta, Ga., in room A301, Georgia World Congress Center.

The complimentary symposium will address atrial fibrillation (AF) from a multifaceted, multidisciplinary approach. Participants will benefit from first-rate knowledge of the guidelines and synopses of cutting-edge developments by the world's leading experts in AF. The program will examine variations among clinicians in these settings, looking at both gaps in knowledge of and adherence to current guidelines as it relates to the future of AF care and its changing climate within the EP and cardiology community.

Participants will benefit from knowledge of the guidelines and synopses of cutting edge developments by some of the world's leading experts in AF. Areas of focus will include: anticoagulation and stroke prevention; cardioversion; heart failure in AF; appropriate selection and endpoints for anti-arrhythmic drug therapy; and patient selection and techniques surrounding catheter ablation to treat AF.

Presenters include Eric N. Prystowsky, M.D., FHRS,?The Care Group LLC; Philip B. Gorelick, M.D., MPH, University of Illinois College of Medicine at Chicago; Jonathan L. Halperin, M.D.,?Mt. Sinai Medical Center; Peter R. Kowey, M.D., FHRS,?Main Line Arrhythmia and Cardiology Consultants at Lankenau Hospital; and Francis E. Marchlinski, M.D., FHRS,?Hospital of the University of Pennsylvania

For more information: http://hrsonline.org/Education/Courses/AFSymp10/

Related Content

A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively 

News | EP Lab | May 15, 2019
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] Th
Studies Find Race and Gender Disparities in Implantable Heart Devices
News | EP Lab | May 15, 2019
May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices, includ
Heart Rhythm 2019 study shows travelers with common cardiac devices can pass through without restrictions or precautions. HRS 2019, #HRS #HRS19

A new study shows travelers with common cardiac devices can pass through airport body scanners without restrictions or precautions.

News | EP Lab | May 14, 2019
May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs), su
News | EP Lab | May 13, 2019
May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their
Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Feature | EP Lab | March 22, 2019
March 22, 2019 — The U.S.
Medtronic Tyrx Envelope Significantly Reduces Major Infections in Cardiac Implantable Device Patients
News | EP Lab | March 20, 2019
Results from the landmark Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT) demonstrated...
Videos | EP Lab | February 27, 2019
This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help o
Seth Worley, M.D., senior consultant, section of cardiac electrophysiology, MedStar Heart and Vascular Institute, developed tools and techniques to optimize transvenous left ventricular (LV) lead implantation, including the I-CRT approach. Here he holds the tools that he personally developed for left ventricular lead implantation to treat heart failure. Photo courtesy of MedStar Heart and Vascular Institute at MedStar Washington Hospital Center.

Seth Worley, M.D., senior consultant, section of cardiac electrophysiology, MedStar Heart and Vascular Institute, developed tools and techniques to optimize transvenous left ventricular (LV) lead implantation, including the I-CRT approach. Here he holds the tools that he personally developed for left ventricular lead implantation to treat heart failure. Photo courtesy of MedStar Heart and Vascular Institute at MedStar Washington Hospital Center.

Feature | EP Lab | January 21, 2019 | Matthew S. McKillop, M.D., FACC, FHRS, and Seth J. Worley, M.D.
Interventional...
An implanted ICD showing its three venous leads. These multiple CRT leads can cause issues when they need to be replaced and are abandoned with new leads put over them in the SVC, which may require lead extraction.

An implanted ICD showing its three leads in the venous system. 

Feature | EP Lab | January 13, 2019 | Dave Fornell, Editor
To extract or abandon broken or infected implantable, venous...
Overlay Init